294 related articles for article (PubMed ID: 34039675)
1. Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease: where to go from here?
Kalluri M; Luppi F; Vancheri A; Vancheri C; Balestro E; Varone F; Mogulkoc N; Cacopardo G; Bargagli E; Renzoni E; Torrisi S; Calvello M; Libra A; Pavone M; Bonella F; Cottin V; Valenzuela C; Wijsenbeek M; Bendstrup E;
Eur Respir Rev; 2021 Jun; 30(160):. PubMed ID: 34039675
[TBL] [Abstract][Full Text] [Related]
2. Patient-reported outcomes to assess dyspnoea in interstitial lung disease and pulmonary hypertension: a systematic literature review of measurement properties.
Lemmers JMJ; Vonk MC; van den Ende CHM
Eur Respir Rev; 2022 Dec; 31(166):. PubMed ID: 36543348
[TBL] [Abstract][Full Text] [Related]
3. Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials.
Saketkoo LA; Mittoo S; Huscher D; Khanna D; Dellaripa PF; Distler O; Flaherty KR; Frankel S; Oddis CV; Denton CP; Fischer A; Kowal-Bielecka OM; LeSage D; Merkel PA; Phillips K; Pittrow D; Swigris J; Antoniou K; Baughman RP; Castelino FV; Christmann RB; Christopher-Stine L; Collard HR; Cottin V; Danoff S; Highland KB; Hummers L; Shah AA; Kim DS; Lynch DA; Miller FW; Proudman SM; Richeldi L; Ryu JH; Sandorfi N; Sarver C; Wells AU; Strand V; Matteson EL; Brown KK; Seibold JR;
Thorax; 2014 May; 69(5):428-36. PubMed ID: 24368713
[TBL] [Abstract][Full Text] [Related]
4. New insights on patient-reported outcome measures in idiopathic pulmonary fibrosis: only PROMises?
Wijsenbeek M; van Manen M; Bonella F
Curr Opin Pulm Med; 2016 Sep; 22(5):434-41. PubMed ID: 27333428
[TBL] [Abstract][Full Text] [Related]
5. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
Hyldgaard C
Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544
[TBL] [Abstract][Full Text] [Related]
6. Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.
Miyashita K; Kono M; Saito G; Koyanagi Y; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Nakamura Y; Suda T; Nakamura H
Clin Respir J; 2021 Mar; 15(3):336-344. PubMed ID: 33197284
[TBL] [Abstract][Full Text] [Related]
7. Review: Serum biomarkers in idiopathic pulmonary fibrosis and systemic sclerosis associated interstitial lung disease - frontiers and horizons.
Jee AS; Sahhar J; Youssef P; Bleasel J; Adelstein S; Nguyen M; Corte TJ
Pharmacol Ther; 2019 Oct; 202():40-52. PubMed ID: 31153954
[TBL] [Abstract][Full Text] [Related]
8. Interstitial Lung Disease in Patients With Systemic Sclerosis: Toward Personalized-Medicine-Based Prediction and Drug Screening Models of Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD).
Khedoe P; Marges E; Hiemstra P; Ninaber M; Geelhoed M
Front Immunol; 2020; 11():1990. PubMed ID: 33013852
[TBL] [Abstract][Full Text] [Related]
9. Family History of Pulmonary Fibrosis Predicts Worse Survival in Patients With Interstitial Lung Disease.
Cutting CC; Bowman WS; Dao N; Pugashetti JV; Garcia CK; Oldham JM; Newton CA
Chest; 2021 May; 159(5):1913-1921. PubMed ID: 33484728
[TBL] [Abstract][Full Text] [Related]
10. Nintedanib: A Review in Fibrotic Interstitial Lung Diseases.
Lamb YN
Drugs; 2021 Apr; 81(5):575-586. PubMed ID: 33765296
[TBL] [Abstract][Full Text] [Related]
11. Disease Behaviour During the Peri-Diagnostic Period in Patients with Suspected Interstitial Lung Disease: The STARLINER Study.
Wijsenbeek MS; Bendstrup E; Valenzuela C; Henry MT; Moor CC; Jouneau S; Fois AG; Moran-Mendoza O; Anees S; Mirt M; Bengus M; Gilberg F; Kirchgaessler KU; Vancheri C
Adv Ther; 2021 Jul; 38(7):4040-4056. PubMed ID: 34117601
[TBL] [Abstract][Full Text] [Related]
12. Comparison of characteristics of connective tissue disease-associated interstitial lung diseases, undifferentiated connective tissue disease-associated interstitial lung diseases, and idiopathic pulmonary fibrosis in Chinese Han population: a retrospective study.
Pan L; Liu Y; Sun R; Fan M; Shi G
Clin Dev Immunol; 2013; 2013():121578. PubMed ID: 24171031
[TBL] [Abstract][Full Text] [Related]
13. Reliability of histopathologic diagnosis of fibrotic interstitial lung disease: an international collaborative standardization project.
Camp R; Smith ML; Larsen BT; Roden AC; Farver C; Moreira AL; Attanoos R; Pillappa R; Sansano I; Fabro AT; Homer RJ
BMC Pulm Med; 2021 Jun; 21(1):184. PubMed ID: 34074264
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of a Clinical Diagnostic Scoring System for the Diagnosis of Idiopathic Pulmonary Fibrosis.
Pastre J; Barnett SD; Ksovreli I; Mogulkoc N; Ramalingam V; Fukuda C; Yelisetty A; Unat ÖS; Brown AW; Shlobin OA; Ahmad K; Khangoora V; Aryal S; King C; Nathan SD
Ann Am Thorac Soc; 2021 Nov; 18(11):1803-1810. PubMed ID: 33844935
[No Abstract] [Full Text] [Related]
15. Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.
Collins BF; Spiekerman CF; Shaw MA; Ho LA; Hayes J; Spada CA; Stamato CM; Raghu G
Chest; 2017 Jul; 152(1):103-112. PubMed ID: 28300570
[TBL] [Abstract][Full Text] [Related]
16. Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA.
Olson AL; Maher TM; Acciai V; Mounir B; Quaresma M; Zouad-Lejour L; Wells CD; De Loureiro L
Adv Ther; 2020 Jul; 37(7):3292-3298. PubMed ID: 32451950
[TBL] [Abstract][Full Text] [Related]
17. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
[TBL] [Abstract][Full Text] [Related]
18. Clinical impact of the interstitial lung disease multidisciplinary service.
Jo HE; Glaspole IN; Levin KC; McCormack SR; Mahar AM; Cooper WA; Cameron R; Ellis SJ; Cottee AM; Webster SE; Troy LK; Torzillo PJ; Corte P; Symons KM; Taylor N; Corte TJ
Respirology; 2016 Nov; 21(8):1438-1444. PubMed ID: 27427515
[TBL] [Abstract][Full Text] [Related]
19. Acute exacerbations of fibrotic interstitial lung diseases.
Suzuki A; Kondoh Y; Brown KK; Johkoh T; Kataoka K; Fukuoka J; Kimura T; Matsuda T; Yokoyama T; Fukihara J; Ando M; Tanaka T; Hashimoto N; Sakamoto K; Hasegawa Y
Respirology; 2020 May; 25(5):525-534. PubMed ID: 31426125
[TBL] [Abstract][Full Text] [Related]
20. ILD-specific health-related quality of life in systemic sclerosis-associated ILD compared with IPF.
Durheim MT; Hoffmann-Vold AM; Eagan TM; Hovden AO; Lund MB; Bjerke G; Birring SS; Jonassen TM; Johansen OE; Sjåheim T
BMJ Open Respir Res; 2020 Jun; 7(1):. PubMed ID: 32576559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
